TITLE

A Prospective, Randomized Trial of 3 or 14 Days of Ciprofloxacin Treatment for Acute Urinary Tract Infection in Patients with Spinal Cord Injury

AUTHOR(S)
Dow, Gordon; Rao, Pramila; Harding, Godfrey; Brunka, Joanna; Kennedy, Jim; Alfa, Michelle; Nicolle, Lindsay E.
PUB. DATE
September 2004
SOURCE
Clinical Infectious Diseases;9/1/2004, Vol. 39 Issue 5, p658
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background. Urinary tract infection (UTI) is common among patients with spinal cord injury. The optimal duration of treatment for symptomatic UTI has not been determined. Methods. A randomized, double-blind, placebo-controlled trial compared 3-day and 14-day regimens of ciprofloxacin, 250 mg twice daily, for the treatment of acute UTI in patients with spinal cord injury. Patients with pyelonephritis, struvite stones, hydronephrosis, or long-term indwelling catheters were excluded from the trial. Results. Sixty patients with spinal cord injury were enrolled in the trial, with 30 patients assigned to each study arm. The most common infecting organisms were Kiebsiella species (30%), Enterococcus species (22%), and Escherichia coli (22%); 33% of the infections were polymicrobial. Microbiological cure at long-term follow-up was significantly better among patients who received therapy for 14 days than among patients who received therapy for 3 days. By 6 weeks of follow-up, microbiological relapse (in 11 [37%] of 30 patients vs. 2 [7%] of 30 patients; 95% confidence interval [CI], 1.38-3.18; P = .01) and symptomatic relapse (in 7 [23%] 30 patients vs. 0 of 30 patients; 95% CI, 1.69-3.13; P = .01) both occurred more frequently in patients treated for 3 days. Reinfection occurred with similar frequency in patients in the 2 study arms. Six of 7 evaluable patients with treatment failure had a fluoroquinolone-resistant organism isolated at enrollment. Conclusions. For patients with spinal cord injury, treatment of acute symptomatic UTI for 14 days leads to improved clinical and microbiological outcomes, compared with short-course therapy.
ACCESSION #
14174151

 

Related Articles

  • Ciprofloxacin 250 mg Twice Daily Versus Ofloxacin 200 mg Twice Daily in the Treatment of Complicated Urinary Tract Infections in Women. Raz, R.; Naber, K. G.; Raizenberg, C.; Rohana, Y.; Unamba-Oparah, I.; Korfman, G.; Yaniv, I. // European Journal of Clinical Microbiology & Infectious Diseases;May2000, Vol. 19 Issue 5, p327 

    In a multicenter, prospective, double-blind, double-dummy randomized study conducted in Israel and Germany, the efficacy and safety of ciprofloxacin 250 mg b.i.d. versus ofloxacin 200 mg b.i.d. was compared in the treatment of women with complicated lower urinary tract infection. A total of 465...

  • Three Days of Ciprofloxacin for UTI in Older Women. Ebell, Mark // American Family Physician;7/15/2004, Vol. 70 Issue 2, p370 

    Focuses on the effectiveness of three days of ciprofloxacin therapy as opposed to seven to 10 days of the same drug in older women with urinary tract infection. Details of a study on ciprofloxacin therapy; Conclusion that the three day treatment of ciprofloxacin twice daily is as effective and...

  • Duration of Therapy for Urinary Tract Infection: The Long and the Short of It. Gupta, Kalpana; Hooton, Thomas M. // Clinical Infectious Diseases;9/1/2004, Vol. 39 Issue 5, p665 

    The diagnosis and management of urinary tract infection (UTI) seem to be a straightforward, task for the busy clinician. In fact, women with acute uncomplicated cystitis often have acute uncomplicated cystitis diagnosed and treated without ever seeing a health care professional, except, perhaps,...

  • 3 days ciprofloxacin adequate for UTI in older women. Vogel, T.; Verreault, R.; Gourdeau, M. // Journal of Family Practice;Jun2004, Vol. 53 Issue 6, p447 

    In this study, women aged over 65 years with a positive urine culture for urinary tract infection (UTI) and at least one symptom of UTI were randomized to receive either oral ciprofloxacin for three days plus placebo for four days or ciprofloxacin twice daily for seven days. This study found...

  • Gatifloxacin best value fluoroquinolone for UTIs.  // PharmacoEconomics & Outcomes News;6/4/2005, Issue 479, p7 

    Discusses research being done on the various types of oral fluoroquinolones for complicated urinary tract infections. Reference to a study by Q. Said et al., published in the April 2005 issue of the "Journal of Managed Care Pharmacy"; Efficacy of gatifloxacin in treating the disease; Analysis...

  • Ciprofloxacin-induced toxic epidermal necrolysis (TEN) in a nonagerian: a case report. Mandal, Bhaskar; Steward, Michael; Singh, Sudhir; Jones, Hywel // Age & Ageing;Jul2004, Vol. 33 Issue 4, p405 

    A 93-year-old lady developed extensive skin lesions following treatment with ciprofloxacin for urinary tract infection. Skin biopsy confirmed toxic epidermal necrolysis. She died within 48 hours of onset of her skin signs in spite of active management. Toxic epidermal necrolysis is a rare but...

  • Optimizing fluoroquinolone utilization in a public hospital: a prospective study of educational intervention. Lacombe, K.; Cariou, S.; Tilleul, P.; Offenstadt, G.; Meynard, J. // European Journal of Clinical Microbiology & Infectious Diseases;Jan2005, Vol. 24 Issue 1, p6 

    Fluoroquinolone (FQ) utilization should be optimized, with the aim of controlling both multidrug-resistant bacteria and costs. In the present study, the appropriateness of FQ prescriptions for urinary tract infections (UTIs) before and after an educational intervention was examined...

  • Once-daily quinolone for complicated UTI. Guttman, Cheryl // Urology Times;Jun2003, Vol. 31 Issue 6, p18 

    Reveals that once-daily ciprofloxacin 1000 mg is as effective as the original 500 mg/twice daily dose for the treatment of complicated urinary tract infection and acute uncomplicated pyelonephritis. Most common pathogen causing the infection; Most common drug-related adverse event.

  • Are the Fluoroquinolones Comparable in the Treatment of Urinary Tract Infections? Naber, K.G. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p330 

    Compares fluoroquinolones for each kind of urinary tract infection (UTI). Discussion on uncomplicated UTI; Information on acute uncomplicated pyelonephritis.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics